Involvement of the Cingulate Cortex in Anosognosia: A Multimodal Neuroimaging Study in Alzheimer’s Disease Patients

BACKGROUND: Anosognosia is a frequent symptom of Alzheimer’s disease (AD), but its neural substrates remain in question. OBJECTIVE: In this study, we combined neuroimaging with a neuropsychological evaluation to assess neural substrates of anosognosia. METHODS: We prospectively recruited 30 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerrier, Laura, Le Men, Johanne, Gane, Anaıs, Planton, Mélanie, Salabert, Anne-Sophie, Payoux, Pierre, Dumas, Hervé, Bonneville, Fabrice, Péran, Patrice, Pariente, Jérémie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130407/
https://www.ncbi.nlm.nih.gov/pubmed/30056422
http://dx.doi.org/10.3233/JAD-180324
Descripción
Sumario:BACKGROUND: Anosognosia is a frequent symptom of Alzheimer’s disease (AD), but its neural substrates remain in question. OBJECTIVE: In this study, we combined neuroimaging with a neuropsychological evaluation to assess neural substrates of anosognosia. METHODS: We prospectively recruited 30 patients with probable early-stage AD and matched healthy controls. Participants underwent MRI, FDG-PET, and a neuropsychological evaluation that includes an assessment of anosognosia. In the AD group, correlations between the anosognosia score, neuroimaging modalities, and neuropsychological performance were performed. RESULTS: Atrophy and hypometabolism were correlated with the anosognosia score in the left dorsal anterior cingulate cortex. The anosognosia score was also correlated with atrophy of the cerebellar vermis, the left postcentral gyrus, and the right fusiform gyrus. No relation was found between anosognosia and the neuropsychological assessment. DISCUSSION: Structural and metabolic alteration in the dorsal anterior cingulate cortex seems to be associated with a diminution of awareness in patients with early-stage AD.